🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology · Phase III

Oncology programs at Phase III — ClinicalTrials.gov pipeline intelligence.

Programs
1,266

Quick answer

Oncology Phase III programs: NovaPharmaNews indexes 1,266 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 26 of 27

  1. gemcitabine and cisplatin (Induction chemotherapy)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  2. gemcitabine and cisplatin (Induction chemotherapy)

    Sun Yat-sen University

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  3. gemcitabine and cisplatin; docetaxel, cisplatin and fluorouracil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  4. gemcitabine,nimotuzumab, toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  5. gene expression analysis

    United Therapeutics Europe Ltd

    Kidney Cancer

    phase 3 gene therapy active

    1 trial

  6. gilteritinib

    Astellas Pharma Inc

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule completed

    1 trial

  7. golidocitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T Cell Lymphoma

    phase 3 small molecule active

    1 trial

  8. innohep® 10.000 anti Xa IU/0,5mL PF.SYR. Ενέσιμο διάλυμα, innohep® 18.000 anti Xa IU/0,9mL PF.SYR. Ενέσιμο διάλυμα, innohep® 14.000 anti Xa IU/0,7mL PF.SYR. Ενέσιμο διάλυμα

    The George Institute

    Thromboprophylaxis in patients with advanced pancreatic cancer

    phase 3 small molecule active

    1 trial

  9. inotuzumab ozogamicin

    Pfizer

    Lymphoma, Follicular

    phase 3 small molecule terminated

    1 trial

  10. intensity-modulated radiation therapy

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 other active

    1 trial

  11. internal mammary nodal irradiation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 3 other active

    1 trial

  12. lapatinib

    GlaxoSmithKline

    Neoplasms, Breast

    phase 3 small molecule completed

    1 trial

  13. lipegfilgrastim

    Teva Pharma GmbH

    Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

    phase 3 small molecule completed

    1 trial

  14. lomustine

    United Therapeutics Europe Ltd

    Brain and Central Nervous System Tumors

    phase 3 small molecule completed

    1 trial

  15. mCapOX plus Cetuximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  16. mRNA-4157, KEYTRUDA 25 mg/mL concentrate for solution for infusion

    Merck Sharp and Dohme

    The participants must have a histologically confirmed diagnosis of resectable cSCC as the primary site of malignancy (metastatic skin involvement from another primary cancer or from an unknown primary cancer is not permitted).

    phase 3 small molecule active

    1 trial

  17. mRNA-4157, Saline solution for Placebo to v940 (mrna-4157), KEYTRUDA 25 mg/mL concentrate for solution for infusion

    Merck Sharp and Dohme

    Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  18. metformin hydrochloride

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  19. mitomycin C-based hyperthermic intraperitoneal chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 other active

    1 trial

  20. nab-paclitaxel combined with carboplatin

    The First People's Hospital of Lianyungang

    Epithelial Ovarian Carcinoma Stage III

    phase 3 small molecule active

    1 trial

  21. neoadjuvant chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Ovarian Cancer

    phase 3 small molecule active

    1 trial

  22. neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2+ Metastatic Breast Cancer (MBC)

    phase 3 small molecule completed

    1 trial

  23. nivolumab

    Bristol-Myers Squibb

    Breast Cancer

    phase 3 mab completed

    1 trial

  24. non-pegylated liposomal doxorubicin

    Teva Pharma GmbH

    Tubular Breast Cancer Stage II

    phase 3 small molecule completed

    1 trial

  25. normal saline solution for infusion, Ociperlimab, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Tislelizumab, Ociperlimab

    BeiGene

    Locally advanced, unresectable, or metastatic non small cell lung cancer

    phase 3 small molecule active

    1 trial

  26. novel stent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 3 other active

    1 trial

  27. obinutuzumab

    Hoffmann-La Roche

    Lymphocytic Leukemia, Chronic

    phase 3 small molecule completed

    1 trial

  28. obrixtamig

    Boehringer Ingelheim

    Small Cell Lung Cancer (SCLC)

    phase 3 small molecule active

    1 trial

  29. oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab

    Takeda

    Colorectal Cancer

    phase 3 small molecule completed

    1 trial

  30. paclitaxel

    United Therapeutics Europe Ltd

    Germ Cell Tumor

    phase 3 small molecule active

    1 trial

  31. paclitaxel/anthracycline

    The First People's Hospital of Lianyungang

    Primary Breast Cancer

    phase 3 small molecule active

    1 trial

  32. patients undergo cVATS segmentectomy

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer Stage I

    phase 3 other active

    1 trial

  33. patients were assigned to receive TNT or iTNT management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  34. pegcyte

    Biotech Pharmaceutical Co.,

    Breast Cancer Female

    phase 3 small molecule completed

    1 trial

  35. pegfilgrastim

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 mab active

    1 trial

  36. pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Non-small Cell Lung Cancer

    phase 3 mab completed

    2 trials

  37. pembrolizumab/vibostolimab

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Non-Small-Cell Lung

    phase 3 mab active

    1 trial

  38. pemetrexed

    Eli Lilly and Company

    Head and Neck Neoplasms

    phase 3 small molecule completed

    1 trial

  39. placebo

    Takeda

    Non-cancer Pain

    phase 3 small molecule terminated

    1 trial

  40. placebo plus docetaxel

    Boehringer Ingelheim

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule completed

    1 trial

  41. postoperative antimicrobial prophylaxis

    Sun Yat-sen University

    Hepatocellular Carcinoma

    phase 3 small molecule on hold

    1 trial

  42. pralatrexate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Peripheral T-Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  43. preoperative short-course radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Neoplasms

    phase 3 other terminated

    1 trial

  44. radiation therapy

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 other completed

    1 trial

  45. ramucirumab

    Eli Lilly and Company

    Gastric Cancer

    phase 3 mab completed

    1 trial

  46. recombinant human erythropoietin

    The First People's Hospital of Lianyungang

    Lymphoma

    phase 3 small molecule active

    1 trial

  47. recombinant interferon alfa

    United Therapeutics Europe Ltd

    Melanoma (Skin)

    phase 3 mab completed

    1 trial

  48. relacorilant, CORT125134, Abraxane 5 mg/ml powder for dispersion for infusion.

    CORCEPT THERAPEUTICS INC

    Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many oncology Phase III programs exist?

1,266 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.